Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

SHE:002755 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,127	1,047	772.71	1,166	1,369	1,187
Trading Asset Securities	955.7	713.83	839.08	522.39	100	100
Cash & Short-Term Investments	2,083	1,761	1,612	1,688	1,469	1,287
Cash Growth	23.18%	9.25%	-4.51%	14.90%	14.14%	15.44%
Accounts Receivable	260.12	181.24	323.03	581.86	968.27	1,052
Other Receivables	12.6	49.88	25.21	16.29	24.79	44.45
Receivables	272.72	231.12	348.23	598.15	993.06	1,097
Inventory	186.55	167.49	141.53	141.84	168.74	226.56
Other Current Assets	18.3	27	36.56	59.14	16.01	24.55
Total Current Assets	2,560	2,186	2,138	2,487	2,647	2,635
Property, Plant & Equipment	468.9	478.4	547.14	658.33	706.66	772.92
Long-Term Investments	119.77	118.21	107.57	105.18	77.36	54.12
Other Intangible Assets	148.92	98.34	95.77	97.69	84.91	87.23
Long-Term Deferred Tax Assets	23.5	25.73	25.85	28.69	26.9	42.17
Long-Term Deferred Charges	587.73	563.46	453.7	342.02	257.47	87.51
Other Long-Term Assets	45.88	53.26	46.22	5.75	7.89	13.24
Total Assets	3,955	3,524	3,414	3,725	3,808	3,692
Accounts Payable	51.48	38.29	39.08	65.72	95.29	275.39
Accrued Expenses	11.45	183.84	119.56	133.48	299.13	476.85
Short-Term Debt	92.03	114.02	45.03	-	20.01	-
Current Portion of Leases	4.28	3.03	3.45	2.61	-	-
Current Income Taxes Payable	21.18	3.59	2.13	7.54	13.14	2.7
Current Unearned Revenue	40.54	15.88	11.68	15.26	31.18	-
Other Current Liabilities	530.55	72.9	102.81	177.11	231.23	323.79
Total Current Liabilities	751.51	431.55	323.74	401.71	689.99	1,079
Long-Term Leases	6.29	6.75	8.92	11.52	-	-
Long-Term Unearned Revenue	61.25	64.72	55.81	68.93	69.41	60.21
Long-Term Deferred Tax Liabilities	10.18	10.18	12.56	15.08	15.49	36.59
Total Liabilities	829.24	513.2	401.03	497.24	774.89	1,176
Common Stock	928.16	928.16	928.16	928.16	928.16	928.16
Additional Paid-In Capital	93.36	136.94	50.73	0.94	1.49	1.31
Retained Earnings	1,955	1,828	1,977	2,295	2,101	1,584
Comprehensive Income & Other	10.79	6.58	7.25	-5.9	-3.7	0.31
Total Common Equity	2,988	2,900	2,963	3,219	3,027	2,514
Minority Interest	138.29	110.7	50.37	8.82	6.06	3.02
Shareholders' Equity	3,126	3,011	3,013	3,228	3,033	2,517
Total Liabilities & Equity	3,955	3,524	3,414	3,725	3,808	3,692
Total Debt	102.6	123.8	57.41	14.13	20.01	-
Net Cash (Debt)	1,980	1,637	1,554	1,674	1,449	1,287
Net Cash Growth	19.81%	5.32%	-7.14%	15.51%	12.58%	15.86%
Net Cash Per Share	2.16	1.76	1.65	1.81	1.57	1.38
Filing Date Shares Outstanding	928.16	928.16	928.16	928.16	928.16	928.16
Total Common Shares Outstanding	928.16	928.16	928.16	928.16	928.16	928.16
Working Capital	1,809	1,755	1,814	2,085	1,957	1,556
Book Value Per Share	3.22	3.12	3.19	3.47	3.26	2.71
Tangible Book Value	2,839	2,802	2,867	3,121	2,942	2,426
Tangible Book Value Per Share	3.06	3.02	3.09	3.36	3.17	2.61
Buildings	-	375.5	371.29	437.94	436.85	434.78
Machinery	-	744.21	767.2	776.51	764.36	743.64
Construction In Progress	-	36.07	29.8	19.71	15.72	15.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.